- Home
- MEG vs ORIC Comparison
MEG vs ORIC Comparison
Compare MEG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEG
- ORIC
- Stock Information
- Founded
- MEG 2012
- ORIC 2014
- Country
- MEG United States
- ORIC United States
- Employees
- MEG N/A
- ORIC N/A
- Industry
- MEG Professional Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MEG Consumer Discretionary
- ORIC Health Care
- Exchange
- MEG Nasdaq
- ORIC Nasdaq
- Market Cap
- MEG 715.9M
- ORIC 735.3M
- IPO Year
- MEG 2020
- ORIC 2020
- Fundamental
- Price
- MEG $17.76
- ORIC $7.68
- Analyst Decision
- MEG Buy
- ORIC Strong Buy
- Analyst Count
- MEG 5
- ORIC 10
- Target Price
- MEG $33.60
- ORIC $19.13
- AVG Volume (30 Days)
- MEG 392.1K
- ORIC 1.6M
- Earning Date
- MEG 02-26-2025
- ORIC 02-18-2025
- Dividend Yield
- MEG N/A
- ORIC N/A
- EPS Growth
- MEG N/A
- ORIC N/A
- EPS
- MEG N/A
- ORIC N/A
- Revenue
- MEG $673,079,000.00
- ORIC N/A
- Revenue This Year
- MEG $13.22
- ORIC N/A
- Revenue Next Year
- MEG $9.55
- ORIC N/A
- P/E Ratio
- MEG N/A
- ORIC N/A
- Revenue Growth
- MEG 12.56
- ORIC N/A
- 52 Week Low
- MEG $15.21
- ORIC $6.33
- 52 Week High
- MEG $49.97
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- MEG 36.23
- ORIC 36.65
- Support Level
- MEG $17.44
- ORIC $7.34
- Resistance Level
- MEG $19.10
- ORIC $14.67
- Average True Range (ATR)
- MEG 1.08
- ORIC 1.56
- MACD
- MEG -0.34
- ORIC -0.45
- Stochastic Oscillator
- MEG 6.82
- ORIC 4.64
About MEG Montrose Environmental Group Inc.
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.